abstract |
Disclosed are methods of treating a hyperproliferative disorder or a disease related to vasculogenesis or angiogenesis in a mammal, comprising administering to said mammal an effective amount of a compound of the formula n n n n n n n n n n or a pharmaceutically accepted salt thereof, wherein A, R 1 , R 2 , R 7 , R 8 , and R 9 are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. |